Unknown NA INTERVENTIONAL 2-arm NCT02099903

Renal Denervation in Patients With Heart Failure Secondary to Chagas Disease

Transcatheter Renal Denervation in Patients With Systolic Heart Failure Due to Chagas' Disease - a Safety and Efficacy Study.

Sponsor: InCor Heart Institute

Conditions Chagas Cardiomyopathy Chagas Disease Heart Failure Heart Failure, Systolic

Interventions transcatheter renal denervation

Updated 6 times since 2017 Last updated: Mar 26, 2014 Started: Mar 31, 2014 Primary completion: Dec 31, 2014 Completion: Aug 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02099903, this NA trial focuses on Chagas Cardiomyopathy and Chagas Disease and remains ongoing. Sponsored by InCor Heart Institute, it has been updated 6 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

InCor Heart Institute
Johnson & Johnson

Data source: InCor Heart Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil